The combination of human glandular Kallikrein and free prostrate- specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA
Angeliki Magklara, Andreas Scorilas, William J. Catalona, Eleftherios P. Diamandis*
Dive into the research topics of 'The combination of human glandular Kallikrein and free prostrate- specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA'. Together they form a unique fingerprint.